• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经口内镜肌切开术治疗贲门失弛缓症患者一年的综合前瞻性随访。

One year comprehensive prospective follow-up of achalasia patients after peroral endoscopic myotomy.

机构信息

Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.

Faculty of Medicine, University of Oslo, Oslo, Norway.

出版信息

Ann Med. 2021 Dec;53(1):2225-2233. doi: 10.1080/07853890.2021.2005253.

DOI:10.1080/07853890.2021.2005253
PMID:34806501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8805855/
Abstract

BACKGROUND AND AIMS

Peroral endoscopic myotomy (POEM) is an established therapy for achalasia, but outcome evaluation has often been limited to Eckardt score (ES). The present study was aimed to improve knowledge about outcome evaluation and predictive outcome factors by performing a comprehensive objective evaluation of achalasia patients treated by POEM.

METHODS

This single centre prospective study reports outcome data 12 months after POEM in treatment-naive achalasia patients. A predefined follow-up protocol included ES, high resolution manometry, 24-h pH measurement, upper endoscopy and timed barium esophagogram (TBE). Univariate and multivariate regression analyses were performed to analyze association between post-POEM variables and identify predictive factors for objective outcome.

RESULTS

Fifty patients were included with a drop-out rate of <5%. ES, lower oesophageal sphincter pressures, TBE heights and maximal oesophageal diameter were all reduced after POEM ( < .001), and 28% (13/47) of the patients had a positive 24-h pH registration. An oesophageal diameter >3 cm after POEM was associated with treatment failure assessed by ES ( = .04) and TBE ( = .03). Advanced achalasia stage ( = .02) and long symptom duration ( = .04) were identified as independent predictive factors for poor outcome assessed by TBE.

CONCLUSIONS

The present study confirms that POEM is an efficient therapy for achalasia. The comprehensive objective evaluation after POEM demonstrates that long symptom duration and major changes in oesophageal anatomy at diagnosis imply poor treatment outcome, and a post-POEM dilated oesophagus is associated with treatment failure.Key messagesPeroral endoscopic myotomy (POEM) is established as a safe and effective therapy for achalasia.Timed barium esophagogram offers objective variables that are valuable in treatment response evaluation. Advanced achalasia stage and long symptom duration are predictive factors for poor objective treatment response after POEM.

摘要

背景与目的

经口内镜下肌切开术(POEM)是治疗贲门失弛缓症的一种成熟疗法,但疗效评估往往仅限于 Eckardt 评分(ES)。本研究旨在通过对接受 POEM 治疗的贲门失弛缓症患者进行全面的客观评估,进一步了解疗效评估和预测疗效的因素。

方法

这是一项单中心前瞻性研究,报告了 POEM 治疗后 12 个月治疗初治贲门失弛缓症患者的结果数据。一项预设的随访方案包括 ES、高分辨率测压、24 小时 pH 测量、上消化道内镜检查和时间分辨钡餐食管造影(TBE)。进行单变量和多变量回归分析,以分析 POEM 后变量与客观结果之间的关系,并确定客观结果的预测因素。

结果

共有 50 例患者入组,失访率<5%。POEM 后 ES、食管下括约肌压力、TBE 高度和食管最大直径均降低(均<0.001),28%(13/47)的患者 24 小时 pH 监测阳性。POEM 后食管直径>3cm 与 ES(=0.04)和 TBE(=0.03)评估的治疗失败相关。晚期贲门失弛缓症(=0.02)和较长的症状持续时间(=0.04)是 TBE 评估的不良预后的独立预测因素。

结论

本研究证实 POEM 是治疗贲门失弛缓症的有效方法。POEM 后的全面客观评估表明,较长的症状持续时间和诊断时食管解剖结构的重大变化提示治疗效果不佳,POEM 后食管扩张与治疗失败相关。

关键信息

经口内镜下肌切开术(POEM)已确立为治疗贲门失弛缓症的安全有效方法。时间分辨钡餐食管造影提供了有价值的治疗反应评估的客观变量。晚期贲门失弛缓症和较长的症状持续时间是 POEM 后客观治疗反应不良的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e8/8805855/ef24d6e9d08d/IANN_A_2005253_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e8/8805855/0ad3cb7b2b73/IANN_A_2005253_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e8/8805855/ef24d6e9d08d/IANN_A_2005253_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e8/8805855/0ad3cb7b2b73/IANN_A_2005253_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e8/8805855/ef24d6e9d08d/IANN_A_2005253_F0002_C.jpg

相似文献

1
One year comprehensive prospective follow-up of achalasia patients after peroral endoscopic myotomy.经口内镜肌切开术治疗贲门失弛缓症患者一年的综合前瞻性随访。
Ann Med. 2021 Dec;53(1):2225-2233. doi: 10.1080/07853890.2021.2005253.
2
Peroral endoscopic myotomy leads to higher rates of abnormal esophageal acid exposure than laparoscopic Heller myotomy in achalasia.经口内镜肌切开术治疗贲门失弛缓症导致食管酸暴露异常的发生率高于腹腔镜 Heller 肌切开术。
Surg Endosc. 2019 Jul;33(7):2284-2292. doi: 10.1007/s00464-018-6522-4. Epub 2018 Oct 19.
3
Peroral endoscopic myotomy laparoscopic myotomy and partial fundoplication for esophageal achalasia: A single-center randomized controlled trial.经口内镜肌切开术、腹腔镜肌切开术和部分胃底折叠术治疗食管失弛缓症:一项单中心随机对照试验。
World J Gastroenterol. 2022 Sep 7;28(33):4875-4889. doi: 10.3748/wjg.v28.i33.4875.
4
Effectiveness of peroral endoscopic myotomy in the treatment of achalasia: a pilot trial in Chinese Han population with a minimum of one-year follow-up.经口内镜下肌切开术治疗贲门失弛缓症的疗效:一项在中国汉族人群中至少随访一年的初步试验。
J Dig Dis. 2014 Jul;15(7):352-8. doi: 10.1111/1751-2980.12153.
5
Peroral endoscopic myotomy for achalasia cardia: Treatment analysis and follow up of over 200 consecutive patients at a single center.经口内镜下贲门肌切开术治疗贲门失弛缓症:单中心200余例连续患者的治疗分析与随访
Dig Endosc. 2016 Jan;28(1):19-26. doi: 10.1111/den.12495. Epub 2015 Jul 30.
6
Clinical efficacy and safety of peroral endoscopic myotomy for esophageal achalasia: A multicenter study in Taiwan.经口内镜肌切开术治疗食管失弛缓症的临床疗效和安全性:台湾的一项多中心研究。
J Formos Med Assoc. 2022 Jun;121(6):1123-1132. doi: 10.1016/j.jfma.2021.10.016. Epub 2021 Nov 6.
7
Outcome of peroral endoscopic myotomy (POEM) in treatment-naive patients. A systematic review.初治患者经口内镜下肌切开术(POEM)的疗效:一项系统评价。
Scand J Gastroenterol. 2019 Jan;54(1):1-7. doi: 10.1080/00365521.2018.1549271. Epub 2019 Jan 16.
8
Safety and efficacy of the modified peroral endoscopic myotomy with shorter myotomy for achalasia patients: a prospective study.改良经口内镜下肌切开术缩短肌切开长度治疗贲门失弛缓症患者的安全性和有效性:一项前瞻性研究
Dis Esophagus. 2015 Nov-Dec;28(8):720-7. doi: 10.1111/dote.12280. Epub 2014 Sep 12.
9
Two-year follow-up for 45 patients with achalasia who underwent peroral endoscopic myotomy.45例接受经口内镜下肌切开术的贲门失弛缓症患者的两年随访。
Eur J Cardiothorac Surg. 2015 May;47(5):890-6. doi: 10.1093/ejcts/ezu320. Epub 2014 Sep 4.
10
Correlation of timed barium esophagography with Eckardt score in primary achalasia patients treated with peroral endoscopic myotomy.经口内镜下肌切开术治疗原发性贲门失弛缓症患者的 timed barium esophagography 与 Eckardt 评分的相关性。
Abdom Radiol (NY). 2022 Feb;47(2):538-546. doi: 10.1007/s00261-021-03379-z. Epub 2021 Dec 17.

引用本文的文献

1
Standard length of peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis.贲门失弛缓症经口内镜肌切开术(POEM)的标准长度:系统评价和荟萃分析。
Dis Esophagus. 2024 Nov 28;37(12). doi: 10.1093/dote/doae069.
2
Intraoperative distensibility measurement in POEM for achalasia: impact on patient outcome and associations with other outcome variables at 1-year follow-up.经口内镜下肌切开术(POEM)中术中可扩张性测量对贲门失弛缓症患者结局的影响:与 1 年随访时其他结局变量的关系。
Surg Endosc. 2023 Dec;37(12):9283-9290. doi: 10.1007/s00464-023-10494-z. Epub 2023 Oct 25.
3
Risk factors for clinical failure of peroral endoscopic myotomy in achalasia.

本文引用的文献

1
ACG Clinical Guidelines: Diagnosis and Management of Achalasia.ACG 临床指南:贲门失弛缓症的诊断与管理。
Am J Gastroenterol. 2020 Sep;115(9):1393-1411. doi: 10.14309/ajg.0000000000000731.
2
Peroral Endoscopic Myotomy Is Safe and Highly Effective Treatment for Advanced Achalasia With Sigmoid Esophagus.经口内镜下肌切开术是治疗乙状结肠型食管重度贲门失弛缓症的安全且高效的方法。
J Clin Gastroenterol. 2021 Jul 1;55(6):505-511. doi: 10.1097/MCG.0000000000001388.
3
Development of a preoperative risk-scoring system for predicting poor responders to peroral endoscopic myotomy.
贲门失弛缓症经口内镜下肌切开术临床失败的危险因素。
Front Med (Lausanne). 2022 Dec 8;9:1099533. doi: 10.3389/fmed.2022.1099533. eCollection 2022.
4
Quality of life in patients with achalasia: Associations with Eckardt score and objective treatment outcomes after peroral endoscopic myotomy.贲门失弛缓症患者的生活质量:与埃卡德特评分及经口内镜下肌切开术后客观治疗结果的相关性
Endosc Int Open. 2022 Dec 15;10(12):E1570-E1576. doi: 10.1055/a-1968-7682. eCollection 2022 Dec.
开发一种术前风险评分系统,以预测经口内镜肌切开术不良反应者。
Gastrointest Endosc. 2021 Feb;93(2):398-405. doi: 10.1016/j.gie.2020.06.028. Epub 2020 Jun 18.
4
Reflux symptoms and oesophageal acidification in treated achalasia patients are often not reflux related.治疗后的贲门失弛缓症患者的反流症状和食管酸化通常与反流无关。
Gut. 2021 Jan;70(1):30-39. doi: 10.1136/gutjnl-2020-320772. Epub 2020 May 21.
5
Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia.特发性贲门失弛缓症患者的内镜或手术肌切开术。
N Engl J Med. 2019 Dec 5;381(23):2219-2229. doi: 10.1056/NEJMoa1905380.
6
Use of a report card to evaluate outcomes of achalasia surgery: beyond the Eckardt score.使用报告卡评估贲门失弛缓症手术的结果:超越 Eckardt 评分。
Surg Endosc. 2020 Apr;34(4):1856-1862. doi: 10.1007/s00464-019-06952-2. Epub 2019 Jul 8.
7
Anterior versus posterior myotomy during poem for the treatment of achalasia: systematic review and meta-analysis of randomized clinical trials.经皮球囊扩张术与肌切开术治疗贲门失弛缓症的比较:随机临床试验的系统评价和荟萃分析。
J Gastrointestin Liver Dis. 2019 Mar;28(1):107-115. doi: 10.15403/jgld.2014.1121.281.pom.
8
Meta-analysis of clinical outcome after treatment for achalasia based on manometric subtypes.基于测压亚型的贲门失弛缓症治疗后临床结局的荟萃分析。
Br J Surg. 2019 Mar;106(4):332-341. doi: 10.1002/bjs.11049. Epub 2019 Jan 28.
9
Outcome of peroral endoscopic myotomy (POEM) in treatment-naive patients. A systematic review.初治患者经口内镜下肌切开术(POEM)的疗效:一项系统评价。
Scand J Gastroenterol. 2019 Jan;54(1):1-7. doi: 10.1080/00365521.2018.1549271. Epub 2019 Jan 16.
10
The effect of prior treatment on clinical outcomes in patients with achalasia undergoing peroral endoscopic myotomy.既往治疗对经口内镜肌切开术治疗贲门失弛缓症患者临床结局的影响。
Endoscopy. 2019 Apr;51(4):307-316. doi: 10.1055/a-0658-5783. Epub 2018 Sep 27.